Gaëtan Jégo
Inserm · 78 works · 5,278 citations · h-index 34
Top works
- Plasmacytoid Dendritic Cells Induce Plasma Cell Differentiation through Type I Interferon and Interleukin 6
- The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.
- Reactive Plasmacytoses Are Expansions of Plasmablasts Retaining the Capacity to Differentiate Into Plasma Cells
- The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
- Interleukin-6 is a growth factor for nonmalignant human plasmablasts
- Targeting heat shock proteins in cancer
- Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors
- CD28, a marker associated with tumoral expansion in multiple myeloma.
- The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells
- Toll‐like receptors – sentries in the B‐cell response
- Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis
- Dendritic Cells Control B Cell Growth and Differentiation
- Toll-like receptors: lessons to learn from normal and malignant human B cells
- Biofilms of Lactobacillus plantarum and Lactobacillus fermentum: Effect on stress responses, antagonistic effects on pathogen growth and immunomodulatory properties
- Cohen syndrome is associated with major glycosylation defects
- Lack of CD27 in myeloma delineates different presentation and outcome
- Hsp70: Anti-apoptotic and Tumorigenic Protein
- Immunotherapy Via Dendritic Cells
- RETRACTED: Extracellular HSP27 mediates angiogenesis through Toll‐like receptor 3
- The biofilm mode of life boosts the anti-inflammatory properties ofLactobacillus